B.C. biotech company says, despite interim approval, provinces won't use its COVID-19 treatment

The CEO of a B.C. biotechnology company says the treatment his firm has developed for COVID-19 is sitting on shelves while people continue to die, despite it being approved for use by Health Canada in the fall.  https://www.cbc.ca/news/politics/abcellera-bamlanivimab-carl-hansen-kapelos-1.5974126?cmp=rss #news/politics